fbpx
×






    *All information provided is confidential and your privacy is protected

    FRANK LEO & ASSOCIATES

    #1 RE/MAX TEAM IN TORONTO & THE GTA**
    #1 RE/MAX TEAM IN CANADA***
    #1 RE/MAX TEAM IN THE WORLD***

    $200 Million Investment to Build New mRNA Vaccine Plant in Ontario

    Today the federal government announced a plan to invest $200-million to build a plant that can produce millions of mRNA vaccines. The investment will go to a Mississauga, Ontario-based company that already has a facility to use. Innovation Minister Francois-Philippe Champagne said the initial investment will be used to expand the existing site owned by Resilience Biotechnologies Inc. 

    The expansion will allow Resilience’s manufacturing and capacity for a number of vaccines and therapeutics to increase and combat COVID-19. There will also be 500 permanent job positions and 50 co-op placements for students when the construction is complete. The government said the expansion will be complete in 2024.

    The additional 55,000 square feet of factory space will increase vaccine output to around 112 million and 640 million does of mRNA per year. The overall goal is to make Canada less dependent on foreign vaccines if another pandemic were to hit. 

    For more information on the source click HERE